JP2020511117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511117A5 JP2020511117A5 JP2019533330A JP2019533330A JP2020511117A5 JP 2020511117 A5 JP2020511117 A5 JP 2020511117A5 JP 2019533330 A JP2019533330 A JP 2019533330A JP 2019533330 A JP2019533330 A JP 2019533330A JP 2020511117 A5 JP2020511117 A5 JP 2020511117A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- nucleic acid
- strand
- cdna
- encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims description 79
- 238000000034 method Methods 0.000 claims description 76
- 239000002299 complementary DNA Substances 0.000 claims description 61
- 150000007523 nucleic acids Chemical group 0.000 claims description 60
- 238000006243 chemical reaction Methods 0.000 claims description 50
- 238000004519 manufacturing process Methods 0.000 claims description 40
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 34
- 229920001184 polypeptide Polymers 0.000 claims description 22
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 22
- 108091034117 Oligonucleotide Proteins 0.000 claims description 20
- 108020004999 messenger RNA Proteins 0.000 claims description 20
- 108020004707 nucleic acids Proteins 0.000 claims description 20
- 102000039446 nucleic acids Human genes 0.000 claims description 20
- 239000000427 antigen Substances 0.000 claims description 18
- 108091007433 antigens Proteins 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 18
- 239000002773 nucleotide Substances 0.000 claims description 15
- 125000003729 nucleotide group Chemical group 0.000 claims description 15
- 238000012986 modification Methods 0.000 claims description 13
- 230000004048 modification Effects 0.000 claims description 13
- 102000003960 Ligases Human genes 0.000 claims description 10
- 108090000364 Ligases Proteins 0.000 claims description 10
- 108091008874 T cell receptors Proteins 0.000 claims description 10
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 10
- 125000006850 spacer group Chemical group 0.000 claims description 10
- 230000036647 reaction Effects 0.000 claims description 8
- 230000006820 DNA synthesis Effects 0.000 claims description 6
- 230000000295 complement effect Effects 0.000 claims description 6
- 108020004635 Complementary DNA Proteins 0.000 claims description 5
- 238000000137 annealing Methods 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 2
- 230000003321 amplification Effects 0.000 claims description 2
- 230000000692 anti-sense effect Effects 0.000 claims description 2
- 239000011324 bead Substances 0.000 claims description 2
- 230000009089 cytolysis Effects 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 108091081021 Sense strand Proteins 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023169621A JP2023169422A (ja) | 2016-12-23 | 2023-09-29 | 結合ポリペプチドおよびそれを作製する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662438712P | 2016-12-23 | 2016-12-23 | |
| US62/438,712 | 2016-12-23 | ||
| PCT/US2017/068204 WO2018119402A1 (en) | 2016-12-23 | 2017-12-22 | Binding polypeptides and methods of making the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023169621A Division JP2023169422A (ja) | 2016-12-23 | 2023-09-29 | 結合ポリペプチドおよびそれを作製する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020511117A JP2020511117A (ja) | 2020-04-16 |
| JP2020511117A5 true JP2020511117A5 (enExample) | 2021-02-12 |
| JP7360324B2 JP7360324B2 (ja) | 2023-10-12 |
Family
ID=61054491
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533330A Active JP7360324B2 (ja) | 2016-12-23 | 2017-12-22 | 結合ポリペプチドおよびそれを作製する方法 |
| JP2023169621A Pending JP2023169422A (ja) | 2016-12-23 | 2023-09-29 | 結合ポリペプチドおよびそれを作製する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023169621A Pending JP2023169422A (ja) | 2016-12-23 | 2023-09-29 | 結合ポリペプチドおよびそれを作製する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11820979B2 (enExample) |
| EP (1) | EP3559028A1 (enExample) |
| JP (2) | JP7360324B2 (enExample) |
| KR (2) | KR102702552B1 (enExample) |
| CN (1) | CN110366557B (enExample) |
| AU (1) | AU2017382367B2 (enExample) |
| BR (1) | BR112019013096A2 (enExample) |
| CA (1) | CA3045696A1 (enExample) |
| CL (2) | CL2019001757A1 (enExample) |
| CO (1) | CO2019006663A2 (enExample) |
| IL (2) | IL315727A (enExample) |
| MX (1) | MX2019007356A (enExample) |
| MY (1) | MY201744A (enExample) |
| RU (1) | RU2019123063A (enExample) |
| WO (1) | WO2018119402A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3781677A4 (en) * | 2018-04-16 | 2022-01-19 | University of Massachusetts | COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITTING |
| CN109161572B (zh) * | 2018-07-05 | 2021-11-12 | 中国海洋大学 | 单链环状核酸及其制备方法和应用 |
| EP3876956A4 (en) | 2018-11-08 | 2022-12-28 | The Regents of The University of California | SYSTEMS AND METHODS FOR TARGETING CANCER CELLS |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| AU600575B2 (en) | 1987-03-18 | 1990-08-16 | Sb2, Inc. | Altered antibodies |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| EP1541682A3 (en) | 1988-09-02 | 2005-07-06 | Dyax Corp. | Generation and selection of recombinant varied binding proteins |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8905669D0 (en) | 1989-03-13 | 1989-04-26 | Celltech Ltd | Modified antibodies |
| WO1991000906A1 (en) | 1989-07-12 | 1991-01-24 | Genetics Institute, Inc. | Chimeric and transgenic animals capable of producing human antibodies |
| ES2087997T3 (es) | 1990-01-12 | 1996-08-01 | Cell Genesys Inc | Generacion de anticuerpos xenogenicos. |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| JPH06508511A (ja) | 1990-07-10 | 1994-09-29 | ケンブリッジ アンティボディー テクノロジー リミティド | 特異的な結合ペアーの構成員の製造方法 |
| WO1992003917A1 (en) | 1990-08-29 | 1992-03-19 | Genpharm International | Homologous recombination in mammalian cells |
| ES2108048T3 (es) | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
| DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
| DE69233769D1 (de) | 1991-03-01 | 2009-09-24 | Dyax Corp | Chimäres Protein mit Mikroprotein mit zwei oder mehr Disulfidbindungen und Ausgestaltungen davon |
| ATE414768T1 (de) | 1991-04-10 | 2008-12-15 | Scripps Research Inst | Bibliotheken heterodimerer rezeptoren mittels phagemiden |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| EP1498427B1 (en) | 1992-08-21 | 2009-12-16 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| US5851804A (en) | 1996-05-06 | 1998-12-22 | Apollon, Inc. | Chimeric kanamycin resistance gene |
| IL127624A0 (en) | 1996-06-17 | 1999-10-28 | Biodynamics Associates | Method and kits for preparing multicomponent nucleic acid constructs |
| US20020086330A1 (en) * | 2000-01-31 | 2002-07-04 | Rosen Craig A. | Nucleic acids, proteins, and antibodies |
| AU2001232204A1 (en) | 2000-02-22 | 2001-09-03 | Ahuva Nissim | Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| KR101135134B1 (ko) * | 2003-09-18 | 2012-04-13 | 심포젠 에이/에스 | 관심있는 서열을 결합시키는 방법 |
| TWI333977B (en) * | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
| US20060199191A1 (en) | 2004-12-13 | 2006-09-07 | Demian Obregon | Methods and compositions for the synthesis of RNA and DNA |
| CN101370832B (zh) * | 2005-12-02 | 2014-07-02 | 健泰科生物技术公司 | 结合多肽及其用途 |
| MX338151B (es) * | 2007-03-01 | 2016-04-05 | Symphogen As | Composiciones de anticuerpo recombinante anti-receptor de factor de crecimiento epidermico. |
| CA2677771A1 (en) | 2007-03-01 | 2008-09-04 | Symphogen A/S | Method for cloning cognate antibodies |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| JP5933894B2 (ja) | 2007-09-14 | 2016-06-15 | アディマブ， エルエルシー | 合理的に設計された、合成抗体ライブラリおよびその使用 |
| SI2274008T1 (sl) * | 2008-03-27 | 2014-08-29 | Zymogenetics, Inc. | Sestavki in metode za zaviranje PDGFRBETA in VEGF-A |
| WO2010005593A1 (en) * | 2008-07-11 | 2010-01-14 | President And Fellows Of Harvard College | Systems and methods of droplet-based selection |
| WO2010022738A1 (en) * | 2008-08-29 | 2010-03-04 | Symphogen A/S | Method for cloning avian-derived antibodies |
| JP5829606B2 (ja) | 2009-06-29 | 2015-12-09 | カリフォルニア・インスティテュート・オブ・テクノロジーＣａｌｉｆｏｒｎｉａ Ｉｎｓｔｉｔｕｔｅ Ｏｆｔｅｃｈｎｏｌｏｇｙ | 単一細胞からの未知の再配列されたｔ細胞受容体の単離 |
| IT1395574B1 (it) | 2009-09-14 | 2012-10-16 | Guala Dispensing Spa | Dispositivo di erogazione |
| JP2013512691A (ja) * | 2009-12-07 | 2013-04-18 | プログノシス バイオサイエンシズ インコーポレイテッド | ペプチド提示アレイ |
| WO2011146514A2 (en) | 2010-05-17 | 2011-11-24 | The Board Of Regents Of The University Of Texas System | Rapid isolation of monoclonal antibodies from animals |
| WO2012032181A2 (en) * | 2010-09-10 | 2012-03-15 | Allozyne, Inc | Novel antibody derivatives |
| US20140057799A1 (en) | 2010-12-16 | 2014-02-27 | Gigagen | System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells |
| EP3421592B1 (en) | 2011-04-28 | 2023-09-13 | The Board of Trustees of the Leland Stanford Junior University | Identification of polynucleotides associated with a sample |
| EP2739733B1 (en) | 2011-08-03 | 2017-11-22 | Texas Biomedical Research Insitute | Nucleic acid compositions, methods and kits for rapid pairing of affinity agents |
| CA2887880A1 (en) | 2011-11-23 | 2013-05-30 | The Board Of Regents Of The University Of Texas System | Proteomic identification of antibodies |
| EP2794652B1 (en) * | 2011-12-21 | 2017-11-15 | F. Hoffmann-La Roche AG | Rapid method for cloning and expression of cognate antibody variable region gene segments |
| EP2809783A2 (en) | 2012-02-02 | 2014-12-10 | Invenra, Inc. | High throughput screen for biologically active polypeptides |
| EP2626433B1 (en) * | 2012-02-09 | 2017-04-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for linking nucleic acids in a microsome from endoplasmatic reticuli |
| WO2013188872A1 (en) * | 2012-06-15 | 2013-12-19 | The Board Of Regents Of The University Of Texas System | High throughput sequencing of multiple transcripts of a single cell |
| CA2876209A1 (en) | 2012-06-15 | 2013-12-19 | Adaptive Biotechnologies Corporation | Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set |
| WO2014043813A1 (en) | 2012-09-19 | 2014-03-27 | British Columbia Cancer Agency Branch | Immune repertoire profiling |
| WO2014144495A1 (en) | 2013-03-15 | 2014-09-18 | Abvitro, Inc. | Single cell bar-coding for antibody discovery |
| SG11201506991VA (en) | 2013-03-15 | 2015-10-29 | Adaptive Biotechnologies Corp | Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set |
| RU2578009C2 (ru) | 2013-05-08 | 2016-03-20 | Закрытое акционерное общество "ЕВРОГЕН" | Способ идентификации нативных пар фрагментов днк или рнк, присутствующих в одних и тех же живых клетках |
| AU2014315287A1 (en) * | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Chimeric polynucleotides |
| GB201402591D0 (en) | 2014-02-14 | 2014-04-02 | Memo Therapeutics Ag | Method for recovering two or more genes, or gene products, encoding an immunoreceptor |
| US10066265B2 (en) | 2014-04-01 | 2018-09-04 | Adaptive Biotechnologies Corp. | Determining antigen-specific t-cells |
| GB201407852D0 (en) * | 2014-05-02 | 2014-06-18 | Iontas Ltd | Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules |
| US10202640B2 (en) | 2014-05-07 | 2019-02-12 | The Board Of Trustees Of The Leland Stanford Junior University | Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing |
| CA2947320C (en) | 2014-05-22 | 2023-03-14 | The University Of British Columbia | Methods for determining lymphocyte receptor chain pairs |
| WO2016044227A1 (en) | 2014-09-15 | 2016-03-24 | Abvitro, Inc. | High-throughput nucleotide library sequencing |
| CA2966201A1 (en) | 2014-10-29 | 2016-05-06 | Adaptive Biotechnologies Corp. | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples |
| US10513733B2 (en) | 2015-03-23 | 2019-12-24 | Board Of Regents, The University Of Texas System | High throughout sequencing of paired VH and VL transcripts from B cells secreting antigen-specific antibodies |
| WO2016176322A1 (en) | 2015-04-27 | 2016-11-03 | Abvitro Llc | Methods of sequencing, determining, pairing, and validating therapeutic agents and disease specific antigens |
| US9422547B1 (en) | 2015-06-09 | 2016-08-23 | Gigagen, Inc. | Recombinant fusion proteins and libraries from immune cell repertoires |
| WO2017180738A1 (en) * | 2016-04-12 | 2017-10-19 | Medimmune, Llc | Immune repertoire mining |
-
2017
- 2017-12-22 CN CN201780086589.3A patent/CN110366557B/zh active Active
- 2017-12-22 EP EP17835907.1A patent/EP3559028A1/en not_active Ceased
- 2017-12-22 US US15/852,718 patent/US11820979B2/en active Active
- 2017-12-22 JP JP2019533330A patent/JP7360324B2/ja active Active
- 2017-12-22 IL IL315727A patent/IL315727A/en unknown
- 2017-12-22 RU RU2019123063A patent/RU2019123063A/ru unknown
- 2017-12-22 CA CA3045696A patent/CA3045696A1/en active Pending
- 2017-12-22 KR KR1020197021677A patent/KR102702552B1/ko active Active
- 2017-12-22 WO PCT/US2017/068204 patent/WO2018119402A1/en not_active Ceased
- 2017-12-22 IL IL267565A patent/IL267565B2/en unknown
- 2017-12-22 MY MYPI2019003039A patent/MY201744A/en unknown
- 2017-12-22 BR BR112019013096A patent/BR112019013096A2/pt unknown
- 2017-12-22 MX MX2019007356A patent/MX2019007356A/es unknown
- 2017-12-22 AU AU2017382367A patent/AU2017382367B2/en active Active
- 2017-12-22 KR KR1020247029164A patent/KR20240133790A/ko active Pending
-
2019
- 2019-06-21 CO CONC2019/0006663A patent/CO2019006663A2/es unknown
- 2019-06-21 CL CL2019001757A patent/CL2019001757A1/es unknown
-
2022
- 2022-02-24 CL CL2022000454A patent/CL2022000454A1/es unknown
-
2023
- 2023-09-29 JP JP2023169621A patent/JP2023169422A/ja active Pending
- 2023-10-05 US US18/481,497 patent/US20240141334A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019122602A (ru) | Комбинации антагонистов pd-1 и циклических динуклеотидных агонистов sting для лечения рака | |
| JP2018538006A5 (enExample) | ||
| JP2020523034A5 (enExample) | ||
| JP2014526899A5 (enExample) | ||
| JP2020503856A5 (enExample) | ||
| JP2020518552A5 (enExample) | ||
| JP2018512155A5 (enExample) | ||
| JP2016524917A5 (enExample) | ||
| JP6506838B2 (ja) | 試験管内淘汰及び分子間相互作用解析用高速光架橋型共用リンカー、そのリンカーを用いた試験管内淘汰方法 | |
| JP2020511117A5 (enExample) | ||
| JPWO2022067130A5 (enExample) | ||
| JP2009518013A5 (enExample) | ||
| US20220089785A1 (en) | Compositions and methods for t-cell receptor gene assembly | |
| CN106319639A (zh) | 构建测序文库的方法及设备 | |
| RU2019123063A (ru) | Связывающие полипептиды и способы их получения | |
| CA2611198C (en) | Methods for the selection of aptamers | |
| JP6513949B2 (ja) | Ｖｄｊ組み換え産物を特定する方法 | |
| PT2110435E (pt) | Método de preparação de uma biblioteca de ácidos nucleicos | |
| CN113913419A (zh) | 二价环状dna链的制备方法、二价环状核酸适体及其应用 | |
| US20230272463A1 (en) | Enrichment of nucleic acid sequences | |
| EP3262185B1 (en) | Dna display and methods thereof | |
| JP2004275194A5 (enExample) | ||
| JPWO2020206238A5 (enExample) | ||
| US12516317B1 (en) | Binding and catalytic molecules built from expanded DNA | |
| US10513704B2 (en) | Binding and catalytic molecules built from L-DNA with added nucleotides |